CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study) Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression - Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation The Future of Cardiovascular Computed Tomography Advanced Analytics and Clinical Insights Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years
|<<... 11 12 13 14 15 16 17 ...>>|

Original Research2018 Aug 27.

JOURNAL：N Engl J Med. Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia JF, Messika-Zeitoun D, MITRA-FR Investigators et al. Keywords: chronic heart failure; reduced left ventricular ejection fraction; severe secondary mitral-valve regurgitation; percutaneous mitral-valve repair;clinical outcome

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top